Home / Omalizumab / Austria
AT ATC R03DX05 · updated 2 Nov 2026
Omalizumab shortage in Austria
Is there an Omalizumab shortage in Austria?
Yes. As of 2 Nov 2026, 6 Omalizumab products are reported short in Austria, the first since 1 Oct 2026. The company estimate for the return is 31 Dec 2026 (latest 31 Mar 2027). Main reason: increased demand.
Also short in Canada, Italy, Spain. All countries.
Affected products in Austria
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| AT | Omlyclo 150 mg Injektionslösung im Fertigpen, 1 Stück limited | Celltrion Healthcare Hungary Ltd. | 1 Oct 2026 | 31 Mar 2027 | Increased demand Erhöhter Mehrbedarf |
| AT | Omlyclo 150 mg Injektionslösung in einer Fertigspritze, 1 Stück limited | Celltrion Healthcare Hungary Ltd. | 1 Oct 2026 | 31 Mar 2027 | Increased demand Erhöhter Mehrbedarf |
| AT | Omlyclo 300 mg Injektionslösung in einer Fertigspritze, 1 Stück | Celltrion Healthcare Hungary Ltd. | 1 Oct 2026 | 31 Dec 2026 | Increased demand Erhöhter Mehrbedarf |
| AT | Omlyclo 75 mg Injektionslösung im Fertigpen, 1 Stück limited | Celltrion Healthcare Hungary Ltd. | 1 Oct 2026 | 31 Mar 2027 | Increased demand Erhöhter Mehrbedarf |
| AT | Omlyclo 75 mg Injektionslösung in einer Fertigspritze, 1 Stück limited | Celltrion Healthcare Hungary Ltd. | 1 Oct 2026 | 31 Mar 2027 | Increased demand Erhöhter Mehrbedarf |
| AT | Omlyclo 300 mg Injektionslösung im Fertigpen, 1 Stück limited | Celltrion Healthcare Hungary Ltd. | 22 Oct 2026 | 31 Mar 2027 | Increased demand Erhöhter Mehrbedarf |
Source
BASG (Austrian Federal Office for Safety in Health Care). Official list. All reported restrictions, listed per pack (PZN).